Skip to main

Contact Vyra Peptides

A source, an exact passage and a clear disagreement are a useful place to begin.

Source errors and new papers

Editorial email: editors@vyrapeptides.com.

For a correction, include the page address, the sentence at issue and the paper or regulatory source that supports the change. An erratum, a mistaken unit or a population described too broadly is particularly useful to flag. A DOI or PubMed identifier makes a source easier to locate.

I welcome disagreement about the comparison, especially when a result has been given more weight than its study design can carry. A newer paper can be relevant even if it overturns an argument here. The current reading list shows which studies the site cites.

Clinical questions

This mailbox cannot assess symptoms, review an individual's medicines, choose a compound or supply preparation instructions. It also cannot arrange access to either peptide. Clinical questions need a licensed clinician with the person's medical history.

Correspondence is for editorial matters and may receive a delayed reply. Do not send private medical records or urgent medical requests.